Gut · 1993 · 68 citations · 22 references
NursingClinical SciencesBowel ManagementGastroenterologyGastrointestinal PharmacotherapyBowel Function AssessmentEnema AdministrationEnema TherapyEnema UseGastrointestinal AssessmentInflammatory Bowel DiseaseBismuth-based TherapyBowel Preparation EnemasClinical RemissionEnema Solution FormulationsHistologic RemissionInflammatory Bowel Disease TherapyUlcerative Colitis Pathology
An enema that contained a complex of bismuth citrate and polyacrylate was compared with 5-aminosalicylic acid (5-ASA) enemas for treatment of distal ulcerative colitis. The multicentre trial involving 63 patients was randomised and double blind with enemas given over four weeks; clinical, sigmoidoscopic, and histological assessments were made. Improvements were seen in both treatment groups. Clinical remission was seen in 18 of 32 patients treated with 5-ASA and 12 of 31 patients treated with bismuth citrate-carbomer (chi 2 1.94; p = 0.16). Sigmoidoscopic remission occurred in 20 of 32 patients in the 5-ASA group and 15 of 31 patients given bismuth (chi 2 1.27; p = 0.26). Improvement of rectal biopsy histology by at least one grade was seen in 16 of 32 patients in the 5-ASA group and 14 of 31 patients with bismuth (chi 2 0.15; p = 0.70). Analysis of covariance gave no significant difference between groups, although there was a trend favouring 5-ASA. There was no evidence of bismuth accumulation during the trial. Bismuth enemas may offer a new therapeutic option in distal ulcerative colitis.
22
Cortisone in Ulcerative Colitis
S. C. Truelove, L. J. Witts · BMJ · 1955 · 2.8K citations · Full text
Medicine, Immunology, Pathobiology +12
Variation Between Observers in Describing Mucosal Appearances in Proctocolitis
J H Baron, Alastair M. Connell, J E Lennard-Jones · BMJ · 1964 · 618 citations · Full text
Medicine, Neurology, Neuroscience +17
Biopsy Studies in Ulcerative Colitis
S. C. Truelove, Warren Richards · BMJ · 1956 · 393 citations · Full text